Patients needing aortic valve replacement who were administered with lower-dose warfarin following implantation were at reduced risk for major and minor bleeding compared with those given the standard-dose anticoagulant therapy, according to findings presented at a thoracic surgery meeting. "In combination with low-dose aspirin, this therapy resulted in significantly lower risk of bleeding than customary aggressive anticoagulation, without significant increase in clots or strokes," said Dr. John D. Puskas of Emory University.
Low-dose anticoagulant OK with aortic valve replacement
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|